Equity Research
Fozia Ahmed, Ph.D.
Equity Research Associate
Fozia Ahmed, Ph.D. is an Equity Research Associate in Biotechnology at Brookline, having joined the firm in December 2025. She brings more than five years of sell-side equity research experience covering SMID-cap biotechnology companies across oncology, metabolic, rare, and autoimmune diseases. Before Brookline, Dr. Ahmed held equity research roles at Rodman & Renshaw, EF Hutton, Roth Capital Partners, and Berenberg Capital Markets.
Dr. Ahmed holds a Ph.D. in Materials Science and Engineering (Biomaterials) and a master’s degree in Biotechnology from Johns Hopkins University, and a B.S. from Denison University.